comparemela.com

Latest Breaking News On - Parliament committee on civil liberties - Page 3 : comparemela.com

Lisbon admits sharing Russian dissidents personal data with Moscow – POLITICO

Lisbon Mayor Fernando Medina is facing calls for his resignation as a result of his government s decision to share the personal information of at least three Lisbon-based Russian dissidents with Russian authorities. Municipal authorities obtained the personal data when the dissidents applied to hold a rally to protest the arrest of Russian opposition leader Alexei Navalny in January. City ordinances require protest organizers to submit their names, identification numbers, home addresses and telephone numbers so that Portugal s Public Security Police (PSP) can contact them if anything goes wrong during the event. Protest organizer Ksenia Ashrafullina, a 36-year-old Russian-Portuguese dual citizen, told POLITICO that when she reviewed her email exchanges with city hall she found evidence that municipal employees had forwarded the data to both the Russian embassy in Lisbon and Russia s Ministry of Foreign Affairs in Moscow.

Coronavirus: Commission proposes update to co-ordinated travel measures ahead of the summer

The European Commission has proposed an update to the Council Recommendation on the coordination of free movement restrictions in the EU, which were put in place in response to the COVID-19 pandemic. As the epidemiological situation is improving and vaccination campaigns are speeding up all over the EU, the Commission is proposing that Member States […]

Additional manufacturing capacity for BioNTech/Pfizer s COVID-19 vaccine

Additional manufacturing capacity for BioNTech/Pfizer’s COVID-19 vaccine Published 1 min ago EMA has recommended the approval of additional manufacturing and filling lines at Pfizer’s vaccine manufacturing site in Puurs, Belgium. The recommendation by the Agency’s Committee for Human Medicines (CHMP) is expected to have a significant and immediate impact on the supply of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, in the European Union. Based on the review of the data submitted by BioNTech Manufacturing GmbH, EMA’s decision reaffirms that the Puurs facility is capable of consistently producing high-quality vaccines and enables Pfizer/BioNTech to increase the volumes of vaccines produced at this site.

Coronavirus: Commission proposes update to coordinated travel measures ahead of the summer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.